跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Grabalin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Grabalin
Approved
STANDARD
Grabalin
Gracure Pharmaceutical Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4e84ddd636a2c21c
Company
Gracure Pharmaceutical Ltd.
Type
Standard
Approval Details
Approval Id
4e84ddd636a2c21c
Drug Approval Philippines Name
Grabalin
Product Name
Grabalin
Registration Number
DR-XY46967
Brand Name
Grabalin
Generic Name
Pregabalin
Dosage Form
Capsule
Dosage Strength
75 mg
Manufacturer
Gracure Pharmaceutical Ltd.
Importer
Aglobal Care, Inc.
Distributor
Aglobal Care, Inc.
Issuance Date
24 July 2020
Expiry Date
24 July 2025
Pharmacologic Category
Anticonvulsant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4e84ddd636a2c21c
Type
Standard
Back to Philippines FDA Approvals